Stocktoria
CervoMed Inc. CRVO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-11-09
CervoMed Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -706.2% | -187.2% | -109.3% | — | — |
| Net margin | -673.1% | -167.3% | -30.4% | — | — |
| Return on assets | -117.9% | -37.8% | -21.8% | -139.6% | -63.7% |
| Return on equity | -148.0% | -41.6% | -29.4% | 17.4% | -69.0% |
| Current ratio | 4.91 | 11.11 | — | — | 12.92 |
| Revenue growth | -58.9% | 36.3% | — | — | — |
Source: SEC EDGAR filings · CIK 0001053691 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.